Dataset Information

Software-aided approach to investigate peptide structure and metabolic susceptibility of amide bonds in peptide drugs based on high resolution mass spectrometry.

ABSTRACT: Interest in using peptide molecules as therapeutic agents due to high selectivity and efficacy is increasing within the pharmaceutical industry. However, most peptide-derived drugs cannot be administered orally because of low bioavailability and instability in the gastrointestinal tract due to protease activity. Therefore, structural modifications peptides are required to improve their stability. For this purpose, several in-silico software tools have been developed such as PeptideCutter or PoPS, which aim to predict peptide cleavage sites for different proteases. Moreover, several databases exist where this information is collected and stored from public sources such as MEROPS and ExPASy ENZYME databases. These tools can help design a peptide drug with increased stability against proteolysis, though they are limited to natural amino acids or cannot process cyclic peptides, for example. We worked to develop a new methodology to analyze peptide structure and amide bond metabolic stability based on the peptide structure (linear/cyclic, natural/unnatural amino acids). This approach used liquid chromatography / high resolution, mass spectrometry to obtain the analytical data from in vitro incubations. We collected experimental data for a set (linear/cyclic, natural/unnatural amino acids) of fourteen peptide drugs and four substrate peptides incubated with different proteolytic media: trypsin, chymotrypsin, pepsin, pancreatic elastase, dipeptidyl peptidase-4 and neprilysin. Mass spectrometry data was analyzed to find metabolites and determine their structures, then all the results were stored in a chemically aware manner, which allows us to compute the peptide bond susceptibility by using a frequency analysis of the metabolic-liable bonds. In total 132 metabolites were found from the various in vitro conditions tested resulting in 77 distinct cleavage sites. The most frequent observed cleavage sites agreed with those reported in the literature. The main advantages of the developed approach are the abilities to elucidate metabolite structure of cyclic peptides and those containing unnatural amino acids, store processed information in a searchable format within a database leading to frequency analysis of the labile sites for the analyzed peptides. The presented algorithm may be useful to optimize peptide drug properties with regards to cleavage sites, stability, metabolism and degradation products in drug discovery.

SUBMITTER: Radchenko T

PROVIDER: S-EPMC5665424 | biostudies-literature | 2017

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

Software-aided approach to investigate peptide structure and metabolic susceptibility of amide bonds in peptide drugs based on high resolution mass spectrometry.

Radchenko Tatiana T Brink Andreas A Siegrist Yves Y Kochansky Christopher C Bateman Alison A Fontaine Fabien F Morettoni Luca L Zamora Ismael I

PloS one 20171101 11

Interest in using peptide molecules as therapeutic agents due to high selectivity and efficacy is increasing within the pharmaceutical industry. However, most peptide-derived drugs cannot be administered orally because of low bioavailability and instability in the gastrointestinal tract due to protease activity. Therefore, structural modifications peptides are required to improve their stability. For this purpose, several in-silico software tools have been developed such as PeptideCutter or PoPS ...[more]

PMID: 29091918

Similar Datasets

Project description:Forensic and clinical laboratories are expected to provide a rapid screening of samples for a wide range of analytes; however, the ever-changing landscape of illicit substances makes analysis complicated. There is a great need for untargeted methods that can aid these laboratories in broad-scope drug screening. Liquid chromatography hyphenated with high-resolution mass spectrometry (LC-HRMS) has become a popular technique for untargeted screening and presumptive identification of drugs of abuse due to its superior sensitivity and detection capabilities in complex matrices. An untargeted extraction and data acquisition method was evaluated for the broad screening of high-priority drugs of abuse in whole blood. A total of 35 forensically relevant target analytes were identified and extracted at biologically relevant low and high (10× low) concentrations from whole blood using supported liquid extraction. Data-independent acquisition was accomplished using ultraperformance liquid chromatography and a quadrupole time-of-flight mass spectrometry. Results were acceptable for screening assays, with limits of detection at or below the recommended low-concentration cutoffs for most analytes. Analyte ionization varied from 30.1 to 267.6% (average: 110.5%) at low concentrations and from 8.6 to 383.5% (average: 93.6%) at high concentrations. Extraction recovery ranged from 8.5 to 330.5% (average: 105.3%) at low concentrations and from 9.4 to 127.5% (average: 82.7%) at high concentrations. This variability was also captured as precision, ranging from 4.7 to 135.2% (average: 36.5%) at low concentrations and from 0.9 to 59.0% (average: 21.7%) at high concentrations. The method described in this work is efficient and effective for qualitative forensic toxicology screening, as demonstrated by analysis of 166 authentic suspected impaired driver and postmortem specimens. That said, it is critical that laboratories establishing untargeted LC-HRMS screening assays be aware of the strengths and limitations across diverse drug categories and chemical structures.

Project description:Software-aided identification facilitates the handling of large sets of bat call recordings, which is particularly useful in extensive acoustic surveys with several collaborators. Species lists are generated by "objective" automated classification. Subsequent validation consists of removing any species not believed to be present. So far, very little is known about the identification bias introduced by individual validation of operators with varying degrees of experience. Effects on the quality of the resulting data may be considerable, especially for bat species that are difficult to identify acoustically. Using the batcorder system as an example, we compared validation results from 21 volunteer operators with 1-26 years of experience of working on bats. All of them validated identical recordings of bats from eastern Austria. The final outcomes were individual validated lists of plausible species. A questionnaire was used to enquire about individual experience and validation procedures. In the course of species validation, the operators reduced the software's estimate of species richness. The most experienced operators accepted the smallest percentage of species from the software's output and validated conservatively with low interoperator variability. Operators with intermediate experience accepted the largest percentage, with larger variability. Sixty-six percent of the operators, mainly with intermediate and low levels of experience, reintroduced species to their validated lists which had been identified by the automated classification, but were finally excluded from the unvalidated lists. These were, in many cases, rare and infrequently recorded species. The average dissimilarity of the validated species lists dropped with increasing numbers of recordings, tending toward a level of ˜20%. Our results suggest that the operators succeeded in removing false positives and that they detected species that had been wrongly excluded during automated classification. Thus, manual validation of the software's unvalidated output is indispensable for reasonable results. However, although application seems easy, software-aided bat call identification requires an advanced level of operator experience. Identification bias during validation is a major issue, particularly in studies with more than one participant. Measures should be taken to standardize the validation process and harmonize the results of different operators.

Dataset Information

Software-aided approach to investigate peptide structure and metabolic susceptibility of amide bonds in peptide drugs based on high resolution mass spectrometry.

Publications

Software-aided approach to investigate peptide structure and metabolic susceptibility of amide bonds in peptide drugs based on high resolution mass spectrometry.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets